FDA Greenlights Bemotrizinol: A New Era for Sunscreen in the U.S.

The FDA has approved bemotrizinol, the first new sunscreen ingredient for the U.S. market in over 25 years, marking a significant update to sun protection options.

- Bemotrizinol provides broad-spectrum protection against both UVA and UVB rays without leaving white streaks. - The ingredient, sold under the brand Parsol Shield, is safe for adults and children 6 months and older.

- It was authorized in Europe in 1999 and finally cleared the FDA after a streamlined process established in 2020. This approval addresses a long-standing gap in U.S.

sunscreen technology, offering consumers a modern alternative to mineral-based and older chemical formulas.